To mark the first World Pneumonia Day, Inter Press Service examines how vaccines and other strategies can be used to combat the disease, which kills more children under age 5 each year “than measles, malaria, and AIDS combined, according to the Global Coalition against Child Pneumonia.”
U.S. Clinical Trials Show Single Dose Of H1N1 Vaccine Protects Pregnant Women, Children Under 10 Need Two Doses
U.S. government data released on Monday confirmed that a single dose of the vaccine protects pregnant women from the virus, while children under the age of 10 years need two doses of the vaccine, the Washington Post reports. The findings came the same day that a team of experts tasked with monitoring the national H1N1 vaccine campaign for any adverse side effects met for the first time.
On Tuesday at the 5th Multilateral Initiative on Malaria (MIM) Pan-African Conference in Nairobi, Kenya, scientists and global health experts focused on malaria eradication, Agence France-Presse reports. “Key among the strategies … is the development of an effective anti-malaria vaccine, a project scientists have been researching since the late 80s. … RTS,S is the most clinically advanced malaria vaccine so far, according to the Malaria Vaccine Initiative,” the news service writes (11/3).
The 5th Multilateral Initiative on Malaria (MIM) Pan-African Conference “kicked off in Nairobi late Sunday with a call for substantial and sustained support for research to guide evidence-based policies and the development of new malaria tools, which together could save countless lives,” Xinhua reports (11/2).
The number of deaths from H1N1 (swine flu) rose by 700 in a week, to top 5,700 since the virus was first identified in April, the WHO reported Friday, Agence France-Presse reports (10/30). “The biggest rise in the past week was recorded in the Americas, w[h]ere 636 more people were reported killed by swine flu, bringing the region’s death toll to 4,175, the UN agency said, AFP reports in a second story. “Fatal cases in Europe also climbed to at least 281, while those in Asia-Pacific rose to 1,070” (10/31).
To mark the first World Pneumonia Day on Monday, the WHO and UNICEF launched a $39 billion Global Action Plan for Prevention and Control of Pneumonia (GAPP) aimed at preventing 5.3 million child deaths from the disease by 2015, the Associated Press reports (Cheng, 11/1).
JAIDS Supplement Focuses On Global Health Systems “Action always leads to reaction, a fundamental law of nature,” write the authors of an introduction appearing in a Journal of Acquired Immune Deficiency Syndromes (JAIDS) supplemental issue that focuses on global health systems. “Central to the debate [over investments in HIV/AIDS spending]…
The New York Times examines how Saudi Arabia is preparing for the upcoming annual pilgrimage of some “2.5 million people from 160 countries” to Mecca, some who “will be bringing the swine flu.”
The U.S. will hold off on donating H1N1 (swine flu) vaccine stockpiles to developing countries until “at-risk Americans” receive the vaccine, HHS Secretary Kathleen Sebelius said Wednesday, Agence France-Presse reports. Last month, the U.S. pledged to donate H1N1 vaccine stockpiles to developing countries. However, manufacturing delays of the H1N1 vaccine have driven the supply to “about 10 million doses short of the 40 million doses they had expected to have by the end of this month,” the news service writes.
GlaxoSmithKline CEO Andrew Witty said Wednesday the company would ensure that if an experimental malaria vaccine works, it would be priced reasonably, Reuters reports. “The vaccine, called Mosquirix [or RTS,S] and the first malaria shot to make it to final-stage trials, is creating a buzz ahead of a conference of 1,500 malaria experts in Nairobi next week,” writes Reuters.